PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Active compounds
Mechanism of action
Clinical evidence
A composite formulation including Pinus strobus bark extract inhibits melanogenesis in B16F10 melanoma cells [PMID:41408899]
Pinostrobin from P. strobus heart-wood has demonstrated anti-viral, anti-oxidant, anti-leukaemic, anti-inflammatory, and anti-aromatase activities [PMID:26653796]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 41408899 (2025) — The Combination of Pterocarpus marsupium Bark Extract, Pinus strobus Bark Extract, and Ascorbyl Tetraisopalmitate Inhibits Melanogenesis via Nicotinamide Nucleotide Transhydrogenase Activation. · Journal of cosmetic dermatology
- 2.PMID: 39338874 (2024) — Monitoring Eastern White Pine Health by Using Field-Measured Foliar Traits and Hyperspectral Data. · Sensors (Basel, Switzerland)
- 3.PMID: 26936598 (2016) — Post-glacial phylogeography and evolution of a wide-ranging highly-exploited keystone forest tree, eastern white pine (Pinus strobus) in North America: single refugium, multiple routes. · BMC evolutionary biology
- 4.PMID: 38304739 (2024) — A Pinus strobus transcription factor PsbHLH1 activates the production of pinosylvin stilbenoids in transgenic Pinus koraiensis calli and tobacco leaves. · Frontiers in plant science
- 5.PMID: 33891091